Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries1

Feikin, Daniel R.; Nelson, Christopher B.; Watt, James P.; Mohsni, Ezzeddine; Wenger, Jay D.; Levine, Orin S.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries1

Published Date:

Jul 2004

Source:

Emerg Infect Dis. 10(7):1270-1276.

Language:

English

[PDF-164.21 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Feikin, Daniel R. ; Nelson, Christopher B. ; Watt, James P. ; Mohsni, Ezzeddine ; Wenger, Jay D. ; ... More ▼

Description:

Haemophilus influenzae type b (Hib) still causes a substantial number of deaths among children in developing countries, despite the availability of effective conjugate vaccines. A major obstacle in developing a Hib vaccine has been limited awareness about the impact of Hib disease. A tool was developed to estimate the national rates of Hib meningitis and pneumonia by assessing retrospective local data over 7 to 10 days. Data from 11 countries in Africa, the Middle East, and Asia were studied and showed rates of Hib meningitis from >50 cases per 100,000 children >5 years in Ghana and Uganda to <15 per 100,000 in Iran, Jordan, and Uzbekistan. Results were affected by the quality of available data. The Hib rapid assessment tool can be useful to countries that desire a timely assessment of Hib disease rates.

Subject:

[+]

Document Type:

Journal Article

Place as Subject:

Africa ; Asia ; Middle East ;

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	03-0737.nxml	text/plain
	license.txt	text/plain
	03-0737-F1.gif	image/gif
	03-0737-F1.jpg	image/jpeg
	03-0737-F2.gif	image/gif
	03-0737-F2.jpg	image/jpeg
	03-0737-F3.gif	image/gif
	03-0737-F3.jpg	image/jpeg
	03-0737-F4.gif	image/gif
	03-0737-F4.jpg	image/jpeg

No Related Documents.

You May Also Like:

Vaccine preventable disease incidence as a complement to vaccine efficacy for setting vaccine policy

Personal Author:

Gessner, Bradford D.; Feikin, Daniel R.;

Published Date:

Apr 13 2014

Source:

Vaccine. 32(26):3133-3138.

Description:

Traditionally, vaccines have been evaluated in clinical trials that establish vaccine efficacy (VE) against etiology-confirmed disease outcomes, a measure important for licensure. Yet, VE does not reflect a vaccine's public health impact because...

File Type:

[PDF - 286.35 KB]
Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group’s experience

Personal Author:

Jauregui, Barbara; Garcia, Ana Gabriela Felix; Janusz, Cara Bess; Blau, Julia; Munier, Aline; Atherly, Deborah; Mvundura, Mercy; Hajjeh, Rana; Lopman, Benjamin; Clark, Andrew David; Baxter, Louise; Hutubessy, Raymond; de Quadros, Ciro; Andrus, Jon Kim;

Published Date:

May 07 2015

Source:

Vaccine. 33(0 1):A28-A33

Description:

IntroductionPan American Health Organization’s (PAHO) ProVac Initiative aims to strengthen countries’ technical capacity to make evidence-based immunization policy. With financial support from the Bill and Melinda Gates Foundation, PAHO establish...

File Type:

[PDF - 139.04 KB]
sodC-Based Real-Time PCR for Detection of Neisseria meningitidis

Personal Author:

Dolan Thomas, Jennifer; Hatcher, Cynthia P.; Satterfield, Dara A.; Theodore, M. Jordan; Bach, Michelle C.; Linscott, Kristin B.; Zhao, Xin; Wang, Xin; Mair, Raydel; Schmink, Susanna; Arnold, Kathryn E.; Stephens, David S.; Harrison, Lee H.; Hollick, Rosemary A.; Andrade, Ana Lucia; Lamaro-Cardoso, Juliana; de Lemos, Ana Paula S.; Gritzfeld, Jenna; Gordon, Stephen; Soysal, Ahmet; Bakir, Mustafa; Sharma, Dolly; Jain, Shabnam; Satola, Sarah W.; Messonnier, Nancy E.; Mayer, Leonard W.;

Published Date:

May 05 2011

Source:

PLoS One. 6(5).

Description:

Real-time PCR (rt-PCR) is a widely used molecular method for detection of Neisseria meningitidis (Nm). Several rt-PCR assays for Nm target the capsule transport gene, ctrA. However, over 16% of meningococcal carriage isolates lack ctrA, rendering thi...

File Type:

[PDF - 144.84 KB]
Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015

Personal Author:

Schuchat, Anne; Anderson, Larry J.; Rodewald, Lance E.; Cox, Nancy J.; Hajjeh, Rana; Pallansch, Mark A.; Messonnier, Nancy E.; Jernigan, Daniel B.; Wharton, Melinda;

Published Date:

Jul 2018

Source:

Emerg Infect Dis. 24(7):1178-1187.

Description:

The need for closer linkages between scientific and programmatic areas focused on addressing vaccine-preventable and acute respiratory infections led to establishment of the National Center for Immunization and Respiratory Diseases (NCIRD) at the Cen...

File Type:

[PDF - 2.66 MB]
Surveillance and control of infectious diseases: progress toward the 1990 objectives.

Personal Author:

Dowdle, W R

Published Date:

1983 May-Jun

Source:

Public Health Rep. 98(3):210-218

Description:

Great progress has been made in the United States in reducing infectious disease mortality. However, infectious diseases remain the greatest cause of morbidity in this country. Newer infectious diseases or agents have been recognized, but newer tools...

File Type:

[PDF - 3.52 MB]